Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.1B |
| 2 |
NVIDIA
NVDA
|
+$737M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$651M |
| 4 |
Advanced Micro Devices
AMD
|
+$570M |
| 5 |
Marvell Technology
MRVL
|
+$500M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.04B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 3 |
Coinbase
COIN
|
+$1.22B |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$569M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.05% |
| 2 | Consumer Discretionary | 1.31% |
| 3 | Financials | 1.07% |
| 4 | Industrials | 0.93% |
| 5 | Healthcare | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8926
CALL
Protara Therapeutics
TARA
$231M
| $43.9K | ﹤0.01% |
+10,300
| New | +$46K |
|
8927
Chegg
CHGG
$94.8M
| $43.4K | ﹤0.01% |
67,897
+30,121
| +80% | +$37.3K |
|
8928
CALL
Solid Biosciences
SLDB
$918M
| $42.9K | ﹤0.01% |
+11,600
| New | +$49.7K |
|
|
RVPH
8929
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $42.8K | ﹤0.01% |
+2,246
| New | +$70.6K |
|
8930
Karyopharm Therapeutics
KPTI
$44.4M
| $42.7K | ﹤0.01% |
11,420
-38,467
| -77% | -$328K |
|
8931
Evogene
EVGN
$7.65M
| $42.2K | ﹤0.01% |
33,732
+12,387
| +58% | +$18.7K |
|
8932
Ocean Power Technologies
OPTT
$50.5M
| $42.1K | ﹤0.01% |
92,277
+51,290
| +125% | +$36.9K |
|
8933
CALL
Sana Biotechnology
SANA
$1B
| $41.5K | ﹤0.01% |
+24,700
| New | +$69K |
|
|
AZUL
8934
DELISTED
Azul
AZUL
| $41.2K | ﹤0.01% |
25,144
-38,102
| -60% | -$74.9K |
|
8935
Noodles & Co
NDLS
$96M
| $41.2K | ﹤0.01% |
+4,726
| New | +$46.5K |
|
8936
CALL
B2Gold
BTG
$6.68B
| $41K | ﹤0.01% |
14,400
-2,100
| -13% | -$5.64K |
|
|
NBTX
8937
Nanobiotix
NBTX
$1.84B
| $40.8K | ﹤0.01% |
11,387
-11,896
| -51% | -$41.1K |
|
8938
CALL
Opko Health
OPK
$1.04B
| $40.7K | ﹤0.01% |
24,500
-168,900
| -87% | -$278K |
|
8939
Biodesix
BDSX
$262M
| $40.6K | ﹤0.01% |
3,245
-647
| -17% | -$12.4K |
|
|
HTZWW
8940
Hertz Global Holdings Warrants
HTZWW
$89.4M
| $40.1K | ﹤0.01% |
17,750
-12,492
| -41% | -$28.3K |
|
8941
CALL
Biomea Fusion
BMEA
$92.1M
| $39.4K | ﹤0.01% |
18,500
-432,100
| -96% | -$1.47M |
|
8942
MediciNova
MNOV
$65M
| $39K | ﹤0.01% |
26,710
+3,451
| +15% | +$6.1K |
|
|
PTPI
8943
DELISTED
Petros Pharmaceuticals
PTPI
| $38.9K | ﹤0.01% |
+22,544
| New | +$115K |
|
8944
PUT
Corvus Pharmaceuticals
CRVS
$1.16B
| $38.8K | ﹤0.01% |
12,200
-57,000
| -82% | -$268K |
|
|
TUYA
8945
PUT
Tuya Inc
TUYA
$1.13B
| $38.8K | ﹤0.01% |
+12,800
| New | +$37.9K |
|
|
DADA
8946
CALL
DELISTED
Dada Nexus
DADA
| $38.7K | ﹤0.01% |
+20,900
| New | +$36K |
|
|
GAN
8947
DELISTED
GAN Ltd
GAN
| $38.3K | ﹤0.01% |
21,650
-8,405
| -28% | -$15.2K |
|
8948
One Stop Systems
OSS
$315M
| $37.9K | ﹤0.01% |
16,332
+3,421
| +26% | +$11.5K |
|
8949
Kopin
KOPN
$780M
| $37.6K | ﹤0.01% |
40,384
-180,095
| -82% | -$265K |
|
8950
Algoma Steel Group Warrant
ASTLW
$314K
| $37.5K | ﹤0.01% |
100,651
-467
| -0.5% | -$424 |
|
Similar funds
Jane Street's Q1 2025 Portfolio in Review
As of Q1 2025, Jane Street held 11,142 positions worth $397B, down 14% from $460B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street withdrew a net $28.5B in Q1 2025, closing 1,903 positions and reducing 3,315 holdings. Its most notable exit was VanEck Gold Miners ETF, an estimated $246M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jane Street opened a new position in CoreWeave worth $349M.
- Jane Street's largest Q1 2025 buy was CoreWeave: 9,401,943 shares worth $349M.
- Jane Street added most to Broadcom in Q1 2025, an estimated $1.1B increase.
- Jane Street's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.04B.
- Jane Street fully exited VanEck Gold Miners ETF in Q1 2025, selling an estimated $246M.
- Jane Street's ten largest holdings make up 38% of its $397B portfolio in Q1 2025.
- Jane Street opened 1,813 new positions and closed 1,903 in Q1 2025.
- Jane Street's portfolio value fell 14% quarter-over-quarter to $397B.
Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.